Literature DB >> 12500425

Identification and characterization of the peptidic component of the immunomodulatory glycoconjugate Immunoferon.

J Varela1, M L Navarro Pico, A Guerrero, F García, G Giménez Gallego, J P Pivel.   

Abstract

Inmunoferon is a glycoconjugate of natural origin, formed by the noncovalent association of a protein from Ricinus communis and a polysacharidic moiety, and endowed with immunomodulatory as well as pharmacological activities. This study investigated the nature of polypeptidic component of Inmunoferon. Through biochemical procedures and comparison with protein databases, the isolated protein was identified as the processed form of the seed of Ricinus communis 2S storage polypeptide, which has been termed RicC3. Further analysis of the isolated protein has revealed that it is composed of two different subunits, alpha and beta, which form an heterodimer of high stability and resistance to denaturation, acidic pH and proteolytic cleavage. These findings confirm the excellent properties of the product after oral administration and provide additional support for the pharmacological activities of Inmunoferon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12500425     DOI: 10.1358/mf.2002.24.8.705066

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  3 in total

1.  AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.

Authors:  Diego Serrano-Gómez; Rocío T Martínez-Nuñez; Elena Sierra-Filardi; Nuria Izquierdo; María Colmenares; Jesús Pla; Luis Rivas; Javier Martinez-Picado; Jesús Jimenez-Barbero; José Luis Alonso-Lebrero; Salvador González; Angel L Corbí
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

2.  AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells.

Authors:  S Martín-Vilchez; F Molina-Jiménez; J L Alonso-Lebrero; P Sanz-Cameno; Y Rodríguez-Muñoz; I Benedicto; P Roda-Navarro; M Trapero; L Aragoneses-Fenoll; S González; J P Pivel; A L Corbí; M López-Cabrera; R Moreno-Otero; P L Majano
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 3.  Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.

Authors:  Diego Fernández-Lázaro; Cesar I Fernandez-Lazaro; Juan Mielgo-Ayuso; David P Adams; Juan Luis García Hernández; Jerónimo González-Bernal; Marcela González-Gross
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.